These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39337633)

  • 1. Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine-Trastuzumab Conjugate.
    Kobzev D; Semenova O; Aviel-Ronen S; Kulyk O; Carmieli R; Mirzabekov T; Gellerman G; Patsenker L
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
    Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
    J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
    Wang P; Li C; Wang X; Xiong W; Feng X; Liu Q; Leung AW; Xu C
    Ultrason Sonochem; 2015 Mar; 23():116-27. PubMed ID: 25465095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of theranostic Trastuzumab-SN38 conjugate for Near-IR fluorescence imaging and targeted therapy of HER2+ breast cancer.
    Kobzev D; Prasad C; Walunj D; Gotman H; Semenova O; Bazylevich A; Patsenker L; Gellerman G
    Eur J Med Chem; 2023 Apr; 252():115298. PubMed ID: 36966651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma.
    An YW; Liu HQ; Zhou ZQ; Wang JC; Jiang GY; Li ZW; Wang F; Jin HT
    Oncol Rep; 2020 Oct; 44(4):1596-1604. PubMed ID: 32945475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Sono-Photodynamic Combination Therapy Mediated by Water-Soluble Gallium Phthalocyanine Enhances the Cytotoxic Effect against Breast Cancer Cell Lines.
    Turkkol A; Can Karanlık C; Calıskan SG; Bilgin MD; Erdoğmuş A; Güzel E
    ACS Appl Bio Mater; 2024 May; 7(5):2725-2733. PubMed ID: 38591733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer.
    Sun L; Zhang J; Xu M; Zhang L; Tang Q; Chen J; Gong M; Sun S; Ge H; Wang S; Liang X; Cui L
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):452-463. PubMed ID: 34961307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
    James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe and Targeted Sonodynamic Cancer Therapy Using Biocompatible Exosome-Based Nanosonosensitizers.
    Nguyen Cao TG; Kang JH; You JY; Kang HC; Rhee WJ; Ko YT; Shim MS
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25575-25588. PubMed ID: 34033477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photosensitizer (PS)-cyanine dye (CD) conjugates: Impact of the linkers joining the PS and CD moieties and their orientation in tumor-uptake and photodynamic therapy (PDT).
    James NS; Joshi P; Ohulchanskyy TY; Chen Y; Tabaczynski W; Durrani F; Shibata M; Pandey RK
    Eur J Med Chem; 2016 Oct; 122():770-785. PubMed ID: 27543778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer.
    Ito K; Mitsunaga M; Nishimura T; Saruta M; Iwamoto T; Kobayashi H; Tajiri H
    Bioconjug Chem; 2017 May; 28(5):1458-1469. PubMed ID: 28402624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancer.
    Wu G; Li L; Qiu Y; Sun W; Ren T; Lv Y; Liu M; Wang X; Tao H; Zhao L; Cao J; He L; Li H; Gu H
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1625-1639. PubMed ID: 34586349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer.
    Lee J; Kida K; Koh J; Liu H; Manyam GC; Gi YJ; Rampa DR; Multani AS; Wang J; Jayachandran G; Lee DW; Reuben JM; Sahin A; Huo L; Tripathy D; Im SA; Ueno NT
    J Exp Clin Cancer Res; 2024 Aug; 43(1):236. PubMed ID: 39164784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).
    Yaghoubi S; Gharibi T; Karimi MH; Sadeqi Nezhad M; Seifalian A; Tavakkol R; Bagheri N; Dezhkam A; Abdollahpour-Alitappeh M
    Breast Cancer; 2021 Jan; 28(1):216-225. PubMed ID: 32889587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonic-responsive piezoelectric stimulation enhances sonodynamic therapy for HER2-positive breast cancer.
    Chen Z; Yang L; Yang Z; Wang Z; He W; Zhang W
    J Nanobiotechnology; 2024 Jun; 22(1):369. PubMed ID: 38918812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the value of Synechococcus 7942 as a sensitizer for photo-sonodynamic therapy against breast cancer.
    Zhao R; Zhao P; Zhou Z; Liu D; Zhou Y; Zheng M; Asakawa T; Kuang X
    Biosci Trends; 2024 Sep; 18(4):335-342. PubMed ID: 39168611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IR-780 Dye as a Sonosensitizer for Sonodynamic Therapy of Breast Tumor.
    Li Y; Zhou Q; Deng Z; Pan M; Liu X; Wu J; Yan F; Zheng H
    Sci Rep; 2016 May; 6():25968. PubMed ID: 27174006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer.
    Tsuru H; Shibaguchi H; Kuroki M; Yamashita Y; Kuroki M
    Free Radic Biol Med; 2012 Aug; 53(3):464-72. PubMed ID: 22588110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancer.
    Watanabe S; Yonesaka K; Tanizaki J; Nonagase Y; Takegawa N; Haratani K; Kawakami H; Hayashi H; Takeda M; Tsurutani J; Nakagawa K
    Cancer Med; 2019 Mar; 8(3):1258-1268. PubMed ID: 30701699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.